Global Bio-pharma Market Survey and Trend Research 2018

December 2017 | 122 pages | ID: G6EE9FCBD52EN
99Strategy

Abstracts

SUMMARY


This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Pfizer, F. Hoffmann-La Roche AG, Johnson & Johnson Services, Sanofi, Amgen, Merck & Co., Merck & Co., Biogen Idec, Bayer AG, Eli Lilly and Company, Novartis AG GlaxoSmithKline Plc, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Bio-pharma Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 BIO-PHARMA MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Pfizer (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 F. Hoffmann-La Roche AG (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Johnson & Johnson Services (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Sanofi, Amgen (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Merck & Co. (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Merck & Co. (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Biogen Idec (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Bayer AG (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Eli Lilly and Company (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Novartis AG GlaxoSmithKline Plc (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Bristol-Myers Squibb Company (Company Overview, Sales Data etc.)
4.12 AstraZeneca PLC (Company Overview, Sales Data etc.)
4.13 Abbott Laboratories (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Bio-pharma Market 2012-2017, by Type, in USD Million
Table Global Bio-pharma Market 2012-2017, by Type, in Volume
Table Global Bio-pharma Market Forecast 2018-2023, by Type, in USD Million
Table Global Bio-pharma Market Forecast 2018-2023, by Type, in Volume
Table Pfizer Overview List
Table Bio-pharma Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F. Hoffmann-La Roche AG Overview List
Table Bio-pharma Business Operation of F. Hoffmann-La Roche AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Services Overview List
Table Bio-pharma Business Operation of Johnson & Johnson Services (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi, Amgen Overview List
Table Bio-pharma Business Operation of Sanofi, Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co. Overview List
Table Bio-pharma Business Operation of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co. Overview List
Table Bio-pharma Business Operation of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biogen Idec Overview List
Table Bio-pharma Business Operation of Biogen Idec (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer AG Overview List
Table Bio-pharma Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly and Company Overview List
Table Bio-pharma Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis AG GlaxoSmithKline Plc Overview List
Table Bio-pharma Business Operation of Novartis AG GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Company Overview List
Table Bio-pharma Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca PLC Overview List
Table Bio-pharma Business Operation of AstraZeneca PLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbott Laboratories Overview List
Table Bio-pharma Business Operation of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Bio-pharma Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Bio-pharma Sales Revenue Share, by Companies, in USD Million
Table Global Bio-pharma Sales Volume 2012-2017, by Companies, in Volume
Table Global Bio-pharma Sales Revenue Share, by Companies in 2017, in Volume
Table Bio-pharma Demand 2012-2017, by Application, in USD Million
Table Bio-pharma Demand 2012-2017, by Application, in Volume
Table Bio-pharma Demand Forecast 2018-2023, by Application, in USD Million
Table Bio-pharma Demand Forecast 2018-2023, by Application, in Volume
Table Global Bio-pharma Market 2012-2017, by Region, in USD Million
Table Global Bio-pharma Market 2012-2017, by Region, in Volume
Table Bio-pharma Market Forecast 2018-2023, by Region, in USD Million
Table Bio-pharma Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Bio-pharma Industry Chain Structure
Figure Global Bio-pharma Market Growth 2012-2017, by Type, in USD Million
Figure Global Bio-pharma Market Growth 2012-2017, by Type, in Volume
Figure Global Bio-pharma Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Bio-pharma Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region